🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/03/2012 | 9,55 | 9,66 | 9,46 | 9,52 | -1,10% | 2,09% | 131.125 |
| 05/03/2012 | 9,23 | 9,63 | 9,18 | 9,63 | +4,40% | 4,87% | 227.305 |
| 02/03/2012 | 9,23 | 9,32 | 9,13 | 9,22 | +0,07% | 2,09% | 139.621 |
| 01/03/2012 | 9,16 | 9,35 | 9,16 | 9,21 | +0,61% | 2,11% | 107.401 |
| 29/02/2012 | 9,36 | 9,36 | 9,09 | 9,16 | -0,20% | 2,87% | 166.872 |
| 28/02/2012 | 9,23 | 9,32 | 9,11 | 9,18 | -0,20% | 2,30% | 58.990 |
| 27/02/2012 | 9,15 | 9,24 | 9,05 | 9,20 | -0,13% | 2,05% | 70.853 |
| 24/02/2012 | 9,25 | 9,33 | 9,18 | 9,21 | -0,47% | 1,62% | 81.593 |
| 23/02/2012 | 9,15 | 9,33 | 9,06 | 9,25 | +1,30% | 3,00% | 151.003 |
| 22/02/2012 | 9,22 | 9,33 | 9,08 | 9,13 | -0,81% | 2,77% | 88.486 |
| 21/02/2012 | 9,55 | 9,66 | 9,20 | 9,21 | -3,02% | 4,77% | 141.385 |
| 17/02/2012 | 9,66 | 9,69 | 9,39 | 9,49 | -1,36% | 3,10% | 110.607 |
| 16/02/2012 | 9,36 | 9,66 | 9,36 | 9,63 | +2,66% | 3,20% | 147.797 |
| 15/02/2012 | 9,66 | 9,68 | 9,36 | 9,38 | -2,15% | 3,36% | 107.722 |
| 14/02/2012 | 9,69 | 9,89 | 9,54 | 9,58 | -2,04% | 3,61% | 179.215 |
| 13/02/2012 | 9,48 | 9,81 | 9,06 | 9,78 | +6,67% | 7,89% | 517.448 |
| 10/02/2012 | 9,14 | 9,63 | 8,86 | 9,17 | +1,59% | 8,40% | 578.042 |
| 09/02/2012 | 8,90 | 9,06 | 8,76 | 9,03 | +1,40% | 3,37% | 235.320 |
| 08/02/2012 | 8,75 | 8,93 | 8,75 | 8,90 | +2,44% | 2,14% | 98.905 |
| 07/02/2012 | 8,73 | 8,79 | 8,38 | 8,69 | -0,64% | 4,65% | 183.223 |
| 06/02/2012 | 8,59 | 8,83 | 8,44 | 8,75 | +1,37% | 4,58% | 117.500 |
| 03/02/2012 | 8,46 | 8,69 | 8,39 | 8,63 | +3,60% | 3,54% | 127.599 |
| 02/02/2012 | 7,99 | 8,33 | 7,90 | 8,33 | +4,21% | 5,46% | 87.844 |
| 01/02/2012 | 7,82 | 8,02 | 7,65 | 7,99 | +2,98% | 4,62% | 117.019 |
| 31/01/2012 | 7,67 | 7,81 | 7,65 | 7,76 | +1,38% | 2,11% | 73.738 |
| 30/01/2012 | 7,67 | 7,74 | 7,49 | 7,65 | -0,41% | 3,34% | 60.754 |
| 27/01/2012 | 7,65 | 7,74 | 7,59 | 7,69 | +0,33% | 1,96% | 61.235 |
| 26/01/2012 | 7,95 | 7,95 | 7,64 | 7,66 | -3,31% | 4,00% | 76.303 |
| 25/01/2012 | 7,89 | 7,96 | 7,79 | 7,92 | +0,71% | 2,21% | 220.092 |
| 24/01/2012 | 7,59 | 7,89 | 7,50 | 7,87 | +3,02% | 5,10% | 238.526 |